164 related articles for article (PubMed ID: 29856571)
1. Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics.
Murray RM; Di Forti M
World Psychiatry; 2018 Jun; 17(2):161-162. PubMed ID: 29856571
[No Abstract] [Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Murray RM; Quattrone D; Natesan S; van Os J; Nordentoft M; Howes O; Di Forti M; Taylor D
Br J Psychiatry; 2016 Nov; 209(5):361-365. PubMed ID: 27802977
[TBL] [Abstract][Full Text] [Related]
4. The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.
Awad AG; Voruganti LN
CNS Drugs; 2013 Aug; 27(8):625-36. PubMed ID: 23757184
[TBL] [Abstract][Full Text] [Related]
5. The use of atypical antipsychotics in Bipolar Spectrum disorders.
Grünze H; Möller HJ
Indian J Psychiatry; 2003 Jan; 45(1):10-5. PubMed ID: 21206806
[TBL] [Abstract][Full Text] [Related]
6. [25 years antipsychotics: back to the future?].
Denys D; de Haan L
Tijdschr Psychiatr; 2008; 50 Spec no.():105-9. PubMed ID: 19067308
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic antipsychotic use for postoperative delirium: a systematic review and meta-analysis.
Hirota T; Kishi T
J Clin Psychiatry; 2013 Dec; 74(12):e1136-44. PubMed ID: 24434102
[TBL] [Abstract][Full Text] [Related]
8. Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia.
Lertxundi U; Hernandez R; Corcóstegui B; Ibarra O; Mentxaka G; Medrano J
Medicine (Baltimore); 2018 Nov; 97(44):e12990. PubMed ID: 30383653
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and metabolism update for some recent antipsychotics.
Caccia S
Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):829-46. PubMed ID: 21476873
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
Leucht S; Pitschel-Walz G; Abraham D; Kissling W
Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841
[TBL] [Abstract][Full Text] [Related]
11. New developments in the pharmacologic treatment of schizoaffective disorder.
Keck PE; McElroy SL; Strakowski SM
J Clin Psychiatry; 1996; 57 Suppl 9():41-8. PubMed ID: 8823349
[TBL] [Abstract][Full Text] [Related]
12. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J
BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026
[TBL] [Abstract][Full Text] [Related]
13. Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
Chatterjee K; Dangi A; Sharma R; Yadav P; Chauhan VS; Prakash J
Ind Psychiatry J; 2022; 31(2):370-373. PubMed ID: 36419690
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland.
Solmi M; Lähteenvuo M; Correll CU; Tanskanen A; Tiihonen J; Taipale H
Schizophr Bull; 2023 Jan; 49(1):78-89. PubMed ID: 36334051
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities.
de Kuijper G; van der Putten AAJ
J Appl Res Intellect Disabil; 2017 Dec; 30 Suppl 1():1-9. PubMed ID: 28467003
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of antipsychotics and their use in the treatment of schizophrenia. What's up, doc?].
Jufe GS
Vertex; 2011; 22(100):423-9. PubMed ID: 22799143
[TBL] [Abstract][Full Text] [Related]
17. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.
Smieskova R; Fusar-Poli P; Allen P; Bendfeldt K; Stieglitz RD; Drewe J; Radue EW; McGuire PK; Riecher-Rössler A; Borgwardt SJ
Curr Pharm Des; 2009; 15(22):2535-49. PubMed ID: 19689326
[TBL] [Abstract][Full Text] [Related]
18. Implementation conditions leading to the scale-up of an innovation involving the optimal use of antipsychotics in long-term care centers: The Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) program.
Couturier Y; Lanneville D; Lane J; Bruneau MA; Morin M; Gilbert S; Boyer D; MacDonald T; Ben Gaied N; Cosette B
Res Social Adm Pharm; 2022 Mar; 18(3):2484-2488. PubMed ID: 33863639
[TBL] [Abstract][Full Text] [Related]
19. How antipsychotics work: the patients' perspective.
Mizrahi R; Bagby RM; Zipursky RB; Kapur S
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):859-64. PubMed ID: 15908094
[TBL] [Abstract][Full Text] [Related]
20. Knowledge and dispensing practice of community pharmacists towards antipsychotic medicines in a Nigerian metropolitan city - a cross-sectional study.
Olasupo J; Taiwo F; Aje A; Fakeye TO
BMC Health Serv Res; 2023 Dec; 23(1):1450. PubMed ID: 38129843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
